Projekt

A randomized trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node

Automatisch geschlossen · 2003 bis 2010

Art
Klinische Forschung
Reichweite
Multizentrisch, KSSG als teilnehmendes Zentrum
Bereiche
Status
Automatisch geschlossen
Start
2003
Ende
2010
Studiendesign
a multi-national, randomized clinical trial
Schlagwörter (Tags)
low- dose chemotherapy regimen
Projektpartner
Dr. Viviana Galimberti, Milano, Italia Dr. Stefano Zurrida Prof. U. Veronesi
Kurzbeschreibung/Zielsetzung

Axillary lymph nodes are often metastatic sites of primary breast cancer and are a major prognostic factor. No reliable non-invasive technique is available for detection of lymph node metastases. In most cases, Level I nodes (below pectoralis minor) are involved first: “skip” metastases to higher levels without Level I involvement are rare. The risk of metastasis correlates directly with the size of the primary tumor. When the primary tumor is less than 1 cm in diameter, the risk of axillary metastasis is about 10%; when it is greater than 5 cm, the risk increases to more than 70%.